Chemical | 15 February 2021
Glenmark Q3 FY21 net profit up 30% at Rs 248 Cr
The jump in profit is due to the better performance of the API business.
The jump in profit is due to the better performance of the API business.
Elementis's personal care business will exclusively sell Aqdot's odor capture and smart fragrance solution Perspirant and Deodorant Formulators
The new plants join two existing ASUs, also built and operated by Linde, to support phase I and II of Wanhua Chemical's integrated chemical site and production center in Yantai, China
The transaction is expected to be completed in the second half of 2021.
The change will enable an enhanced customer centered approach, management focus and decision-making, strengthened resource allocation, and increased transparency and accountability as per the company
The company is setting up greenfield BOPET and CPP lines in Karnataka to meet the growing demand.
The company has posted net profit of Rs.2301.31 crores for the 9 months period ended December 31, 2020
The company continued to maintain clear FDA status across its plants and has received 12 ANDA approvals during 9MFY21
Jubilant announced the completion of demerger of pharma and LSI business into two separate companies
The company posted net profit of Rs.35.82 crores for the period ended December 31, 2019.
The company has posted net profit loss of Rs. 3.78 crores for the period ended December 31, 2019.
The company posted net profit loss of Rs.1.12 crores for the period ended December 31, 2019.
The company s posted net loss of Rs. 1.38 crores for the period ended December 31, 2019.
It posted net profit of Rs.9.28 crores for the period ended December 31, 2019.
The company posted net profit of Rs.683.94 crores for the period ended December 31, 2019.
The company posted net profit of Rs.25.37 crores for the period ended December 31, 2019.
Pfizer Limited (PFL) reported an operationally strong performance in the quarter. Revenue grew 10.3% YoY to Rs6.0bn (I-Sec: Rs6.0bn) as company is benefiting from its vitamins / minerals / nutrients (VMN) portfolio in the current environment. EBITDA margin jumped 840bps YoY to 33.2% (I-Sec: 29.8%) driven by lower S, G&A costs and adjusted PAT grew 25.2% YoY to Rs1.4bn.
The centralized marketing authorization granted by the EC is valid in all EU Member
The new facility further expands the company’s capacity and reinforces its leading supply position in Penang to serve the fast-growing customer demand from the electrical and electronics (E&E) and other manufacturing industries
The pandemic has provided tailwinds in terms of access to rural healthcare and India’s emergence as a vaccine powerhouse
Subscribe To Our Newsletter & Stay Updated
_195_291.jpg){kind=logo}
